• Something wrong with this record ?

Exploring the Synthetic Chemistry of Phenyl-3-(5-aryl-2-furyl)- 2-propen-1-ones as Urease Inhibitors: Mechanistic Approach through Urease Inhibition, Molecular Docking and Structure-Activity Relationship

M. Fatima, S. Aslam, AM. Zafar, A. Irfan, MA. Khan, M. Ashraf, S. Faisal, S. Noreen, GA. Shazly, BR. Shah, YA. Bin Jardan

. 2023 ; 11 (9) : . [pub] 20230830

Status not-indexed Language English Country Switzerland

Document type Journal Article

Grant support
Researchers Supporting Project Number (RSP2023R457) The Researchers Supporting Project Number (RSP2023R457), King Saud University, Riyadh, Saudi Arabia.

Furan chalcone scaffolds belong to the most privileged and promising oxygen-containing heterocyclic class of compounds, which have a wide spectrum of therapeutic applications in the field of pharmaceutics, pharmacology, and medicinal chemistry. This research described the synthesis of a series of twelve novel and seven reported furan chalcone (conventional synthetic approach) analogues 4a-s through the application of microwave-assisted synthetic methodology and evaluated for therapeutic inhibition potential against bacterial urease enzyme. In the first step, a series of nineteen substituted 5-aryl-2-furan-2-carbaldehyde derivatives 3a-s were achieved in moderate to good yields (40-70%). These substituted 5-aryl-2-furan-2-carbaldehyde derivatives 3a-s were condensed with acetophenone via Claisen-Schmidt condensation to furnish 19 substituted furan chalcone scaffolds 4a-s in excellent yields (85-92%) in microwave-assisted synthetic approach, while in conventional methodology, these furan chalcone 4a-s were furnished in good yield (65-90%). Furan chalcone structural motifs 4a-s were characterized through elemental analysis and spectroscopic techniques. These nineteen (19)-afforded furan chalcones 4a-s were screened for urease inhibitory chemotherapeutic efficacy and most of the furan chalcones displayed promising urease inhibition activity. The most active urease inhibitors were 1-phenyl-3-[5-(2',5'-dichlorophenyl)-2-furyl]-2-propen-1-one 4h with an IC50 value of 16.13 ± 2.45 μM, and 1-phenyl- 3-[5-(2'-chlorophenyl)-2-furyl] -2-propen-1-one 4s with an IC50 value of 18.75 ± 0.85 μM in comparison with reference drug thiourea (IC50 = 21.25 ± 0.15 μM). These furan chalcone derivatives 4h and 4s are more efficient urease inhibitors than reference drug thiourea. Structure-activity relationship (SAR) revealed that the 2,5-dichloro 4h and 2-chloro 4s moiety containing furan chalcone derivatives may be considered as potential lead reagents for urease inhibition. The in silico molecular docking study results are in agreement with the experimental biological findings. The results of this study may be helpful in the future drug discovery and designing of novel efficient urease inhibitory agents from this biologically active class of furan chalcones.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015374
003      
CZ-PrNML
005      
20231020093627.0
007      
ta
008      
231010s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biomedicines11092428 $2 doi
035    __
$a (PubMed)37760869
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Fatima, Miraj $u Department of Chemistry, The Women University, Multan 66000, Pakistan $1 https://orcid.org/0000000335412796
245    10
$a Exploring the Synthetic Chemistry of Phenyl-3-(5-aryl-2-furyl)- 2-propen-1-ones as Urease Inhibitors: Mechanistic Approach through Urease Inhibition, Molecular Docking and Structure-Activity Relationship / $c M. Fatima, S. Aslam, AM. Zafar, A. Irfan, MA. Khan, M. Ashraf, S. Faisal, S. Noreen, GA. Shazly, BR. Shah, YA. Bin Jardan
520    9_
$a Furan chalcone scaffolds belong to the most privileged and promising oxygen-containing heterocyclic class of compounds, which have a wide spectrum of therapeutic applications in the field of pharmaceutics, pharmacology, and medicinal chemistry. This research described the synthesis of a series of twelve novel and seven reported furan chalcone (conventional synthetic approach) analogues 4a-s through the application of microwave-assisted synthetic methodology and evaluated for therapeutic inhibition potential against bacterial urease enzyme. In the first step, a series of nineteen substituted 5-aryl-2-furan-2-carbaldehyde derivatives 3a-s were achieved in moderate to good yields (40-70%). These substituted 5-aryl-2-furan-2-carbaldehyde derivatives 3a-s were condensed with acetophenone via Claisen-Schmidt condensation to furnish 19 substituted furan chalcone scaffolds 4a-s in excellent yields (85-92%) in microwave-assisted synthetic approach, while in conventional methodology, these furan chalcone 4a-s were furnished in good yield (65-90%). Furan chalcone structural motifs 4a-s were characterized through elemental analysis and spectroscopic techniques. These nineteen (19)-afforded furan chalcones 4a-s were screened for urease inhibitory chemotherapeutic efficacy and most of the furan chalcones displayed promising urease inhibition activity. The most active urease inhibitors were 1-phenyl-3-[5-(2',5'-dichlorophenyl)-2-furyl]-2-propen-1-one 4h with an IC50 value of 16.13 ± 2.45 μM, and 1-phenyl- 3-[5-(2'-chlorophenyl)-2-furyl] -2-propen-1-one 4s with an IC50 value of 18.75 ± 0.85 μM in comparison with reference drug thiourea (IC50 = 21.25 ± 0.15 μM). These furan chalcone derivatives 4h and 4s are more efficient urease inhibitors than reference drug thiourea. Structure-activity relationship (SAR) revealed that the 2,5-dichloro 4h and 2-chloro 4s moiety containing furan chalcone derivatives may be considered as potential lead reagents for urease inhibition. The in silico molecular docking study results are in agreement with the experimental biological findings. The results of this study may be helpful in the future drug discovery and designing of novel efficient urease inhibitory agents from this biologically active class of furan chalcones.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Aslam, Samina $u Department of Chemistry, The Women University, Multan 66000, Pakistan $u Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan
700    1_
$a Zafar, Ansa Madeeha $u Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan $u Department of Chemistry, Government Sadiq Women University, Bahawalpur 63100, Pakistan $1 https://orcid.org/0000000162776486
700    1_
$a Irfan, Ali $u Department of Chemistry, Government College University Faisalabad, Faisalabad 38000, Pakistan $1 https://orcid.org/0000000289773303
700    1_
$a Khan, Misbahul Ain $u Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan
700    1_
$a Ashraf, Muhammad $u Department of Biotechnology and Biochemistry, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan
700    1_
$a Faisal, Shah $u Department of Chemistry, Islamia College University Peshawar, Peshawar 25120, Pakistan $1 https://orcid.org/0000000251056982
700    1_
$a Noreen, Sobia $u Institute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan $1 https://orcid.org/0000000208152223
700    1_
$a Shazly, Gamal A $u Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
700    1_
$a Shah, Bakht Ramin $u Skin Barrier Research Group, Faculty of Pharmacy in Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000270781434
700    1_
$a Bin Jardan, Yousef A $u Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia $1 https://orcid.org/0000000333024036
773    0_
$w MED00205373 $t Biomedicines $x 2227-9059 $g Roč. 11, č. 9 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37760869 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20231020093621 $b ABA008
999    __
$a ok $b bmc $g 1997119 $s 1201736
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 11 $c 9 $e 20230830 $i 2227-9059 $m Biomedicines $n Biomedicines $x MED00205373
GRA    __
$a Researchers Supporting Project Number (RSP2023R457) $p The Researchers Supporting Project Number (RSP2023R457), King Saud University, Riyadh, Saudi Arabia.
LZP    __
$a Pubmed-20231010

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...